Search research articles
Contact Us
Filters
Showing results (91-100 of 107) with videos related to
Page
of 11
Sort By:
Open Forum Infectious Diseases
|
January 29, 2020
Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy
Catalina Barceló, Monia Guidi, Christian W Thorball, et al.
Pharmaceutics
|
September 23, 2022
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
Thomas Rodier, Alicja Puszkiel, Evelina Cardoso, et al.
Pharmaceutics
|
July 27, 2022
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer
Perrine Courlet, Evelina Cardoso, Carole Bandiera, et al.
Cancers
|
January 8, 2023
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study
Carole Bandiera, Isabella Locatelli, Perrine Courlet, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 5, 2021
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib study
Imke H Bartelink, Pierre M Bet, Nicolas Widmer, et al.
Molecules (Basel, Switzerland)
|
May 14, 2025
A Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Cystic Fibrosis Drugs (Caftors) in Plasma and Its Application for Therapeutic Monitoring
Valentina D'Atri, Fabrizio Corrado, François Versace, et al.
British Journal of Clinical Pharmacology
|
March 25, 2021
Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial
Perrine Courlet, Charlotte Barbieux, Delphine Sculier, et al.
Pharmacogenetics and Genomics
|
November 1, 2012
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals
Rubin Lubomirov, Mona Arab-Alameddine, Margalida Rotger, et al.
Frontiers in Psychiatry
|
June 5, 2023
Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project
Anaëlle Monfort, Evelina Cardoso, Chin B Eap, et al.
Cancers
|
April 15, 2020
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma
David Balakirouchenane, Sarah Guégan, Chantal Csajka, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 107) with videos related to
Sort By:
Page
of 11
Open Forum Infectious Diseases
|
January 29, 2020
Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy
Catalina Barceló, Monia Guidi, Christian W Thorball, et al.
Pharmaceutics
|
September 23, 2022
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
Thomas Rodier, Alicja Puszkiel, Evelina Cardoso, et al.
Pharmaceutics
|
July 27, 2022
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer
Perrine Courlet, Evelina Cardoso, Carole Bandiera, et al.
Cancers
|
January 8, 2023
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study
Carole Bandiera, Isabella Locatelli, Perrine Courlet, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 5, 2021
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib study
Imke H Bartelink, Pierre M Bet, Nicolas Widmer, et al.
Molecules (Basel, Switzerland)
|
May 14, 2025
A Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Cystic Fibrosis Drugs (Caftors) in Plasma and Its Application for Therapeutic Monitoring
Valentina D'Atri, Fabrizio Corrado, François Versace, et al.
British Journal of Clinical Pharmacology
|
March 25, 2021
Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial
Perrine Courlet, Charlotte Barbieux, Delphine Sculier, et al.
Pharmacogenetics and Genomics
|
November 1, 2012
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals
Rubin Lubomirov, Mona Arab-Alameddine, Margalida Rotger, et al.
Frontiers in Psychiatry
|
June 5, 2023
Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project
Anaëlle Monfort, Evelina Cardoso, Chin B Eap, et al.
Cancers
|
April 15, 2020
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma
David Balakirouchenane, Sarah Guégan, Chantal Csajka, et al.
Page
of 11